SymbolNCEL
NameNLS PHARMACEUTICS LTD.
SectorHEALTH CARE
RegionEurope
IndustryBiotechnology: Pharmaceutical Preparations
AddressTHE CIRCLE 6, ZURICH, 8058, Switzerland
Telephone+41 445122150
Fax
Email
Websitehttps://www.nlspharma.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001783036
Description

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The companys tangible assets are held in the United States.

Additional info from NASDAQ:
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The companys tangible assets are held in the United States.

2026-08-20 17:16

New Form F-3 - NewcelX Ltd. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001213900-26-092117 <b>Size:</b> 693 KB

Read more
2026-07-31 13:00

NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing

Read more
2026-07-08 13:15

NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board

Read more
2026-07-01 13:30

NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes

Read more
2026-06-18 07:04

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 9999999995-26-002036 <b>Size:</b> 1 KB

Read more
2026-06-10 17:16

New Form F-3/A - NewcelX Ltd. <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001213900-26-067333 <b>Size:</b> 724 KB

Read more
2026-05-27 11:55

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

Read more
2026-05-18 07:04

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 9999999995-26-001675 <b>Size:</b> 1 KB

Read more
2026-05-11 18:07

New Form F-3 - NewcelX Ltd. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001213900-26-054555 <b>Size:</b> 751 KB

Read more
2026-05-07 07:06

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 9999999995-26-001512 <b>Size:</b> 1 KB

Read more